NCT00350376

Brief Summary

The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2006

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 5, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 10, 2006

Completed
Last Updated

July 10, 2006

Status Verified

July 1, 2006

First QC Date

July 5, 2006

Last Update Submit

July 5, 2006

Conditions

AsthmaAllergies

Keywords

asthmaallergiesXolairAdvair

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Age GroupsAdult (18-64)

You may qualify if:

  • Have asthma and allergies
  • Currently taking Xolair® or Advair®
  • Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair® for at least 12 months
  • Between 18 and 55 years of age
  • A non-smoker for at least 6 months
  • Have internet access

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ovation Research Group

San Francisco, California, 94105, United States

RECRUITING

MeSH Terms

Conditions

AsthmaHypersensitivity

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateImmune System Diseases

Study Officials

  • Susan D Mathias, MPH

    Ovation Research Group

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nita Ngo, MPH

CONTACT

888.631.9167asthmastudy@ovation.org

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
OTHER
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

July 5, 2006

First Posted

July 10, 2006

Study Start

June 1, 2006

Last Updated

July 10, 2006

Record last verified: 2006-07

Locations

US(1)